Neha Panjwani
2 min read
In This Article:
Pasadena, California-based Alexandria Real Estate Equities, Inc. (ARE) is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. Valued at $12.3 billion by market cap, the company acquires, manages, expands, and develops office and laboratory space properties. It leases its properties to pharmaceutical, biotechnology, diagnostic and personal care products companies, research institutions, and related government agencies.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and ARE perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the REIT - office industry. ARE has pioneered life science real estate, establishing itself as a market leader, by focusing on innovation-driven sectors like life science, agtech, and technology. Strategic investments in Class A properties and collaborative environments create a dynamic ecosystem, boosting competitiveness. With a presence in key markets like Greater Boston, San Francisco Bay Area, and New York City, ARE benefits from geographical diversity, mitigating risks and unlocking revenue opportunities.
Despite its notable strength, ARE slipped 45.2% from its 52-week high of $130.14, achieved on Jul. 18, 2024. Over the past three months, ARE stock declined 26.4%, underperforming the Real Estate Select Sector SPDR Fund’s (XLRE) marginal losses during the same time frame.
In the longer term, shares of ARE dipped 26.8% on a YTD basis and fell 38.1% over the past 52 weeks, significantly underperforming XLRE’s YTD gains of 2.9% and 9% returns over the last year.
To confirm the bearish trend, ARE has been trading below its 50-day moving average over the past year, experiencing some fluctuations. The stock is trading below its 200-day moving average since late July, 2024, with some fluctuations.
ARE's underperformance is due to ongoing weakness in the office real estate market, exacerbated by remote work trends.
On Apr. 28, ARE reported its Q1 results, and its shares closed down more than 5% in the following trading session. Its adjusted FFO of $2.30 per share surpassed Wall Street expectations of $2.28 per share. The company’s revenue was $758.2 million, topping Wall Street forecasts of $749.5 million. ARE expects full-year adjusted FFO in the range of $9.16 to $9.36 per share.
